Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
Great place to work with the opportunity to make a real difference!
Quais são algumas das melhores coisas da sua equipe?
Strong commitment to help each other succeed.
O que você mais gosta nos lideres?
Very transparent and very patient focused
O que faz você mais feliz no trabalho?
The opportunity to make a difference every day
Qual é a melhor parte das suas compensações?
Great overall package of benefits.
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
Fast paced and energetic environment
Other Employee Reviews for Karyopharm Therapeutics
×